Overall survival and graft failure rates at 1, 6, and 12 months for patients who received lung transplants for irreversible lung injuries after SARS-CoV-2 infection mirrored the rates of those who received the transplants for other reasons, according to a study of data from 385 people located around the US.
Source: JAMA Online First